Physician profile
Mark A Oyer
NPI 1679968812
$102,195.23
in general payments reported to CMS, 2019-2025
14 companies · $52K in 2025
The $52K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,060 · 2020: $2,717 · 2021: $694 · 2022: $3,306 · 2023: $16K · 2024: $27K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $84K · Travel and Lodging: $6,029 · Food and Beverage: $4,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $84,062.50 |
| Travel and Lodging | $6,029.33 |
| Food and Beverage | $4,326.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $92,788.55 | 2020-2025 | Velys, Emphasys, Reclaim |
| Depuy Synthes Sales INC. | $5,359.26 | 2019-2025 | Velys, Attune, Actis |
| Smith+Nephew, INC. | $1,496.21 | 2022 | |
| Stryker Corporation | $1,464.48 | 2019-2023 | Fixos, Hoffmann |
| Zimmer Biomet Holdings, INC. | $536.12 | 2021-2023 | Gel-One Cross-Linked Hyaluronate, Rosa |
| Omnilife Science, INC | $154.35 | 2023 | Omnibotics 3.0 |
| Medacta USA, INC. | $114.94 | 2019 | |
| Orthofix Medical, INC. | $114.01 | 2019 | |
| Wright Medical Technology, INC. | $73.01 | 2020 | |
| Ethicon US, LLC | $27.27 | 2022 | |
| Vericel Corporation | $20.61 | 2019 | |
| Pacira Therapeutics, INC. | $18.27 | 2019 | |
| Convatec INC. | $16.61 | 2022 | |
| Heraeus Medical, LLC. | $11.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Oyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.